We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
TG Therapeutics Inc is a biopharmaceutical company. It is engaged in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. The company is developing two therapies targeting hematologic malignancies. TG-1101 (ublituximab) is a novel, ... TG Therapeutics Inc is a biopharmaceutical company. It is engaged in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. The company is developing two therapies targeting hematologic malignancies. TG-1101 (ublituximab) is a novel, glycoengineered monoclonal antibody that targets a unique epitope on the CD20 antigen found on mature B-lymphocytes. It is also developing TGR-1202 (umbralisib), an orally available PI3K delta inhibitor. Show more
Ask ADVFN Intelligence (AI)
Third quarter 2024 U.S. BRIUMVI net revenue of $83.3 million Raises full year 2024 U.S. BRIUMVI net revenue target to $300 - $305 million Conference call to be held today, November 4, 2024, at...
NEW YORK, Nov. 01, 2024 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that a conference call will be held, Monday November 4, 2024, at 8:30 AM ET to discuss results...
| Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 6.54 | 26.7047774602 | 24.49 | 31.55 | 23.6 | 3907243 | 28.26733909 | CS |
| 4 | 8 | 34.737299175 | 23.03 | 31.55 | 22.61 | 3296229 | 25.73809769 | CS |
| 12 | 5.86 | 23.2816845451 | 25.17 | 31.55 | 21.11 | 3523728 | 24.34448585 | CS |
| 26 | 14.28 | 85.2537313433 | 16.75 | 31.55 | 15.16 | 3192781 | 21.85487952 | CS |
| 52 | 20.86 | 205.113077679 | 10.17 | 31.55 | 9.81 | 3827477 | 18.32660684 | CS |
| 156 | -2.4 | -7.17918037691 | 33.43 | 35.67 | 3.48 | 3857197 | 14.5650094 | CS |
| 260 | 23.48 | 310.993377483 | 7.55 | 56.74 | 3.48 | 3005355 | 17.32914364 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
